Malaria Clinical Trial
Official title:
Estivation of Malaria Vector Mosquitoes in the Sahelian Region of Mali (Village of Thierola in the District of Banamba)
| Verified date | March 10, 2010 |
| Source | National Institutes of Health Clinical Center (CC) |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
Background:
- P. falciparum, one of the most virulent forms of malaria, causes more than 300 million
episodes of malaria and 1 million deaths each year. The spread of drug-resistant
parasites, insecticide-resistant mosquitoes, and persistent socioeconomic conditions of
poverty compound the difficulties of malaria as a major global health problem. New means
of disease and vector control are vitally needed.
- Several promising strategies rely on targeting mosquito populations when they are most
vulnerable, such as during the dry season when mosquitoes find it difficult to
reproduce. Large regions of the West African country of Mali have prolonged dry seasons
(up to 8 months), during which mosquito populations dramatically decline within a month
after the rainfall ceases. Clearly, mosquitoes can survive the dry season (as evident
from their robust numbers during the wet season) but the process that enables them to do
so remains unknown. Targeting the small and fragile mosquito population at the end of
the dry season could reduce or eliminate the numbers of mosquitoes in certain regions,
providing great benefits for communities in dry regions.
Objectives:
- To determine if common malaria-carrying mosquitoes survive the dry season in the Mali
village of Thierola by estivation (going dormant, or hibernating, during dry periods).
- To identify and examine mosquitoes that were marked with special paint during a previous
protocol, if these marked mosquitoes are captured during the investigation.
Eligibility:
- All activities in this protocol will take place in Thierola village, Banamba district,
Koulikoro region, Mall, West Africa. The village was chosen because it is isolated from
other communities by at least 6 km and is a small community of less than 300 inhabitants
living in 90 houses.
- Participants will be healthy adult men between 18 and 65 years of age.
Design:
- Thirty adult men who live in Thierola will be recruited to participate as mosquito
collectors for the human-baited trapping method and will work in teams of two.
- The first collector will expose his lower legs to attract human-seeking mosquitoes.
Using a mouth aspirator, the second collector will collect the mosquitoes as they land
on the first collector's legs.
- The collections will be conducted both indoors and outdoors from 6 p.m. to 6 a.m. the
following morning for 14 consecutive days.
- All study volunteers will be trained in proper collection technique and supervised
throughout the study by a mobile team led by the study investigators. Volunteers will be
monitored for signs of malaria and treated accordingly if they develop symptoms of the
disease.
- Researchers will collect mosquito samples at the end of the dry season (April-May) and
at the start of the rainy season (May-June).
- Mosquitoes collected in the study will be analyzed by NIH researchers to learn more
about how they survive during the dry season.
| Status | Completed |
| Enrollment | 0 |
| Est. completion date | March 10, 2010 |
| Est. primary completion date | |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Male |
| Age group | 18 Years to 65 Years |
| Eligibility |
- INCLUSION CRITERIA: - Age 18-65 years - Only healthy male adults who are free of acute and chronic illnesses will participate. - Permanent residency in Thierola - Ability to collect mosquitoes after being trained |
| Country | Name | City | State |
|---|---|---|---|
| United States | National Institutes of Health Clinical Center, 9000 Rockville Pike | Bethesda | Maryland |
| Lead Sponsor | Collaborator |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) |
United States,
Beier JC, Killeen GF, Githure JI. Short report: entomologic inoculation rates and Plasmodium falciparum malaria prevalence in Africa. Am J Trop Med Hyg. 1999 Jul;61(1):109-13. — View Citation
Hay SI, Rogers DJ, Toomer JF, Snow RW. Annual Plasmodium falciparum entomological inoculation rates (EIR) across Africa: literature survey, Internet access and review. Trans R Soc Trop Med Hyg. 2000 Mar-Apr;94(2):113-27. Review. — View Citation
Simard F, Lehmann T, Lemasson JJ, Diatta M, Fontenille D. Persistence of Anopheles arabiensis during the severe dry season conditions in Senegal: an indirect approach using microsatellite loci. Insect Mol Biol. 2000 Oct;9(5):467-79. — View Citation
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04601714 -
Baseline Cohort Malaria Morbidity Study
|
||
| Withdrawn |
NCT04020653 -
A Study to Assess the Safety and Efficacy of 5-aminolevulinic Acid Hydrochloride (5-ALA HCl) and Sodium Ferrous Citrate (SFC) Added on Artemisinin-based Combination Therapy (ACT) in Adult Patients With Uncomplicated Malaria
|
Phase 2 | |
| Terminated |
NCT04368910 -
Safety and Efficacy of Pyronaridine Artesunate Vs Chloroquine in Children and Adult Patients With Acute Vivax Malaria
|
Phase 3 | |
| Completed |
NCT03641339 -
Defining Skin Immunity of a Bite of Key Insect Vectors in Humans
|
N/A | |
| Completed |
NCT02544048 -
Markers of T Cell Suppression: Antimalarial Treatment and Vaccine Responses in Healthy Malian Adults
|
||
| Completed |
NCT00527163 -
Role of Nitric Oxide in Malaria
|
||
| Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
| Active, not recruiting |
NCT04704674 -
Community Dynamics of Malaria Transmission in Humans and Mosquitoes in Fleh-la and Marshansue, Salala District, Bong County, Liberia
|
||
| Completed |
NCT03276962 -
Efficacy, Safety and Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine (SB257049) Evaluating Schedules With or Without Fractional Doses, Early Dose 4 and Yearly Doses, in Children 5-17 Months of Age
|
Phase 2 | |
| Completed |
NCT04966871 -
Safety, Tolerability and Efficacy of PfSPZ Vaccine Against Heterologous CHMI in US Malaria naïve Adults
|
Phase 1 | |
| Completed |
NCT00289185 -
Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine in Tanzanian Infants
|
Phase 2 | |
| Recruiting |
NCT03937817 -
Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
|
||
| Active, not recruiting |
NCT06153862 -
Africa Ready Malaria Screening
|
N/A | |
| Completed |
NCT04545905 -
Antenatal Care as a Platform for Malaria Surveillance: Utilizing Community Prevalence Measures From the New Nets Project to Validate ANC Surveillance of Malaria in Burkina Faso
|
||
| Recruiting |
NCT06278181 -
Diabetes, Metabolic Syndrome and Risk of Malaria in Cameroon
|
||
| Completed |
NCT02909712 -
Cardiac Safety of Dihydroartemisinin-Piperaquine Amongst Pregnant Women in Tanzania
|
Phase 2 | |
| Withdrawn |
NCT02793388 -
A Trial on Supervised Primaquine Use in Ethiopia
|
Phase 4 | |
| Completed |
NCT02793622 -
Prevention of Malaria in HIV-uninfected Pregnant Women and Infants
|
Phase 3 | |
| Withdrawn |
NCT02793414 -
Diagnostic Utility of Volatile Organic Compounds in Human Breath for Acute Clinical Malaria in Ethiopia
|
||
| Completed |
NCT02605720 -
Cardiac Safety of Repeated Doses of Dihydroartemisinin-Piperaquine for the Use in Mass Treatment Campaigns
|
Phase 3 |